Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Predictors of kidney dysfunction in heart transplant recipients

P Przybyłowski, J Małyszko, J Małyszko

Ann Transplant 2009; 14(1): 32-32 :: ID: 880314

Abstract

Background: Cardiovascular disease and kidney disease seem to be lethally synergistic and both approach the level of epidemic. Patients with cardiovascular disease have often impaired kidney function, while on the other hand cardiovascular disease is the single best predictor of mortality in patients with chronic kidney disease. The risk in a patient with moderate impaired renal function is comparable in magnitude with that of a patient with diabetes mellitus. The aim of the study was to assess the risk factors for kidney dysfunction in a 162 consecutive heart transplant recipients (129 males, 22 females). Stages of chronic kidney disease were defi ned according to K/DOQI guidelines using estimated GFR.
Results: Mean serum creatinine in this population was 1.70±1.08 mg/dl (ranges from 0.54-9.34 mg/dl); mean age was 54±14 years; mean time after transplantation was 106±52 months (ranges 10-210 months). Mean GFR was 62.92±31.04 ml/min (Cockcroft-Gault formula), 55.38±26.74 ml/min (MDRD) and 62.62±35.61 ml/min (creatinine clearance). Estimated GFR, creatinine clearance, serum creatinine correlated in univariate analysis with haemoglobin, RBC count, age, time after transplantation, ejection fraction, NT-proBNP, use of calcineurine inhibitors. In multiple regression analysis predictors of kidney function (GFR) were age (beta value -0.47, p<0.001), time after transplantation (beta value -0.22, p=0.03) and haemoglobin (beta value 0.31, p-0.03) explaining the 51% of variation of GFR in this group. When GFR was substituted by creatinine clearance the results were the same. Conclusions: In heart transplant recipients kidney function is predominantly dependent upon age, time after transplantation (both non-modifi able causes) and anaemia (which could be modified).

Keywords: Heart Transplantation, Immunosuppression

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358